Nidya News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nidya. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nidya Today - Breaking & Trending Today

6,726 Shares in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Acquired by Callan Capital LLC

Callan Capital LLC acquired a new position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,726 shares of the company’s stock, valued at approximately $239,000. Other hedge funds have also […] ....

United States , Yujiros Hata , Briseno Andres Ruiz , Leerink Partnrs , Werner Helicase , Jpmorgan Chase Co , Eventide Asset Management , Barclays Plc , Biosciences Inc , Goldman Sachs Group , Walleye Capital , Callan Capital , Boone Capital Management , Hermes Inc , Securities Exchange Commission , Exchange Commission , Free Report , Capital Management , One Financial , Get Free Report , Pol Theta Helicase , Visit Holdingschannel , Ideaya Biosciences , Nasdaq Idya , Sec Filings , Hedge Fund Holdings ,

IDEAYA Biosciences (NASDAQ:IDYA) Shares Down 3.2%

IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) fell 3.2% during trading on Thursday . The company traded as low as $38.88 and last traded at $38.90. 88,103 shares changed hands during mid-day trading, a decline of 90% from the average session volume of 847,028 shares. The stock had previously closed at $40.17. Analyst Ratings […] ....

Nova Scotia , United States , Werner Helicase , Leerink Partnrs , Yujiros Hata , Briseno Andres Ruiz , Capital Research Global Investors , Royal Bank , Ideaya Biosciences Inc , Goldman Sachs Group , Blackrock Inc , Securities Exchange Commission , Fisher Asset Management , Pricet Rowe Associates Inc , Vanguard Group Inc , Biosciences Inc , Get Free Report , Exchange Commission , Research Global Investors , Asset Management , Vanguard Group , Pol Theta Helicase , Ideaya Biosciences , Nasdaq Idya ,

IDEAYA Biosciences (NASDAQ:IDYA) PT Raised to $60.00 at Citigroup

IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its target price upped by Citigroup from $40.00 to $60.00 in a report published on Thursday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages have also recently issued reports on IDYA. Leerink Partnrs reiterated an outperform rating on shares […] ....

United States , Hong Kong , Leerink Partnrs , Briseno Andres Ruiz , Werner Helicase , Yujiros Hata , Biosciences Inc , Life Insurance Co , China Universal Asset Management Co , Hong Kong Ltd , Goldman Sachs Group , Jpmorgan Chase Co , Biosciences Company Profile , Free Report , One Financial , Trading Down , Get Free Report , Kong Ltd , Universal Asset Management , Pol Theta Helicase , Ideaya Biosciences , Nasdaq Idya , Boost Price Target , Citigroup Inc ,

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives $40.42 Average PT from Analysts

IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) has been given an average recommendation of “Buy” by the thirteen analysts that are presently covering the firm, MarketBeat.com reports. Thirteen research analysts have rated the stock with a buy rating. The average twelve-month price objective among analysts that have issued ratings on the stock in the […] ....

United States , New Zealand General , New Zealand , Leerink Partnrs , Werner Helicase , Yujiros Hata , Briseno Andres Ruiz , Securities Exchange Commission , American International Group Inc , Ideaya Biosciences Inc , Biosciences Inc , Wellington Management Group , Fisher Asset Management , Jpmorgan Chase Co , Vanguard Group Inc , Biosciences Company Profile , Virtu Financial , Get Free Report , Capital One Financial , Exchange Commission , Asset Management , Management Group , International Group , Stock Down , Get Free , Pol Theta Helicase ,

IDEAYA Biosciences (NASDAQ:IDYA) PT Raised to $57.00 at JPMorgan Chase & Co.

IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its price objective boosted by JPMorgan Chase & Co. from $51.00 to $57.00 in a report issued on Friday, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. Several other research analysts have also weighed in on the company. Royal Bank of Canada […] ....

Briseno Andres Ruiz , Yujiros Hata , Halpern Financial Inc , Jpmorgan Chase Co , China Universal Asset Management Co , Royal Bank , Biosciences Inc , Life Insurance Co , Goldman Sachs Group , Securities Exchange Commission , Biosciences Company Profile , Free Report , One Financial , Get Free Report , Exchange Commission , Universal Asset Management , Ideaya Biosciences , Nasdaq Idya , Boost Price Target , Jpmorgan Chase Co ,